GO
| HSI1 | 26,033.26 | +174.37 | 200.88B |
| HSCEI1 | 9,172.84 | +42.66 | 76.25B |
| Back Zoom + Zoom - Block Traded | |
|
2025-12-01 11:27:56 UBS issued a research report on YUE YUEN IND (00551.HK), of which management revealed that the OEM margin improved in 3Q compared to 1H, thanks to reduced overtime, increased worker familiarity with orders, and a more stable US tariff policy. UBS believed some orders were brought forward to 4Q for production. The broker expected the company's 4Q sales volume to subside YoY, but the ASP was expected to elevate. Looking ahead to 2026, UBS anticipated that the recovery of individual brands may entail benefits. Vibrant sales during the upcoming holiday season and hyped brand confidence will also favor YUE YUEN IND's sales and attract new brand clients. UBS raised its target price on YUE YUEN IND from HK$18 to HK$18.4 with a Buy rating. ~ AAStocks Financial News Web Site: www.aastocks.com | |